tiprankstipranks

Robert Klupacs Insider Profile

4 Followers
Robert Klupacs, Director at Bio-Gene Technology Ltd., holds 565.12K shares in Epiminder Ltd. (Ticker: AU:EPI), holds 3.96M shares in Bio-Gene Technology Ltd. (Ticker: AU:BGT), holds 475.45K shares in Opthea (Ticker: CKDXF). Most recently, Robert Klupacs Bought ― shares of Epiminder Ltd. on May 15, 2026 for an estimated value of AU$4.69K.
tipranks
Robert  Klupacs

Robert Klupacs
Bio-Gene Technology Ltd. (BGT)
Director

Ranked #23,538 out of 107,514 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

+9.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$407K
43.94%
33.18%
22.88%
A breakdown of Robert Klupacs's holdings

Insider Roles

Epiminder Ltd.
(EPI)
Director
Opthea
(CKDXF)
Managing Director & Chief Executive Officer
Bio-Gene Technology Ltd.
(BGT)
Director
Roles that Robert Klupacs holds in companies

Most Profitable Insider Trade

Stock:
Bio-Gene Technology Ltd.
(BGT)
Rating:Informative Buy
Date:Mar 01, 2021 - Mar 01, 2022
Return:+134.40%
The most profitable trade made by Robert Klupacs

Robert Klupacs's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bio-Gene Technology Ltd.
Jun 16, 2022
Director
Informative Buy
3.61K
AU$114.73K
Opthea
May 23, 2013
Managing Director & Chief Executive Officer
Informative Buy
10.92K
$166.41K
Epiminder Ltd.
May 15, 2026
Director
Informative Buy
4.69K
AU$220.40K
List of latest transactions for each holding click on a transaction to see Robert Klupacs's performance on stock

Robert Klupacs insider profile FAQ

What is the percentage of profitable transactions made by Robert Klupacs?
The percentage of profitable transactions made by Robert Klupacs is 43%.
    What is the average return per transaction made by Robert Klupacs?
    The average return per transaction made by Robert Klupacs is 9.90%.
      What stocks does Robert Klupacs hold?
      Robert Klupacs holds: AU:BGT, CKDXF, AU:EPI stocks.
        What was Robert Klupacs’s latest transaction?
        Robert Klupacs latest transaction was an Informative Buy of AU$4.69K.
          What was Robert Klupacs's most profitable transaction?
          Robert Klupacs’s most profitable transaction was an Informative Buy of AU:BGT stock on March 1, 2021. The return on the trade was 134.40%.
            What is Robert Klupacs's role in Bio-Gene Technology Ltd.?
            Robert Klupacs's role in Bio-Gene Technology Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.